top
Search terms
Results 1 - 10 of 26 - ordered by :
Pages: 1 2 3
Ehjcvp

The Systolic Blood Pressure Intervention Trial (SPRINT) enrolled 9300 participants age 50 years and older without diabetes or previous stroke in 100 expert medical centres and clinical practices ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Sverre E. Kjeldsen, Giuseppe Mancia

Date : 01/04/2016 Item size : 128053 bytes
Ehjcvp

Abstract Aims We compared clinical outcomes in patients with AF with and without diabetes in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Justin A. Ezekowitz, Basil S. Lewis, Renato D. Lopes, Daniel M. Wojdyla, John J.V. McMurray, Michael Hanna, Dan Atar, M. ...

Date : 01/04/2015 Item size : 304584 bytes
Ehjcvp

Optimization of heart failure medication after cardiac resynchronization therapy and the impact on long-term survival Abstract Aims Treatment with evidence-based heart failure (HF) medication ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Christoffer Tobias Witt, Mads Brix Kronborg, Ellen Aagaard Nohr, Peter Thomas Mortensen, Christian Gerdes, Jens Cosedis ...

Date : 01/07/2015 Item size : 273569 bytes
Ehjcvp

Furthermore, it is noteworthy that the lack of a carboxyl terminus renders CNP highly susceptible to cleavage by neprilysin (NEP).6 Physiologically CNP via activation of pGC-B exhibits antifibrotic ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Johann Wojta

Date : 01/04/2016 Item size : 144952 bytes
Ehjcvp

In this issue of the journal, Sverre E. Kjeldsen and Giuseppe Mancia comment on the measurement technique for blood pressure (BP) that was used in the important SPRINT study, and they discuss whether ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Stefan Agewall

Date : 01/04/2016 Item size : 103672 bytes
Ehjcvp

SerelaxinAcute heart failureCongestion reliefOrgan protectionLong-term outcomesIntroduction Heart failure (HF) is a chronic condition, punctuated by acute episodes, which affects as many as one in ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Javier Díez, Luis M. Ruilope

Date : 01/04/2016 Item size : 577165 bytes
Ehjcvp

Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patients Patients on digitalis were more ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLES, Julia W. Erath, Mate Vamos, Stefan H. Hohnloser

Date : 01/07/2016 Item size : 225615 bytes
Ehjcvp

Abstract Cardiovascular disease is the leading cause of morbidity and mortality among patients with diabetes, underscoring the importance of choosing anti-diabetic drugs that do not increase ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, R. Kumar, D. M. Kerins, T. Walther

Date : 01/01/2016 Item size : 517106 bytes
Ehjcvp

Introduction The presence of atrial fibrillation (AF) increases the risk of stroke and thrombo-embolism, and given how common AF is, this represents a considerable healthcare and public health ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Gregory Y.H. Lip

Date : 01/04/2015 Item size : 213366 bytes
Ehjcvp

Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used drugs, but much attention has been focused on the relationship of these drugs to cardiovascular conditions.1 In this issue of European ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Marco Proietti, Gregory Y.H. Lip

Date : 01/04/2015 Item size : 163809 bytes